Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy
<p>Abstract</p> <p>Background</p> <p>Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene <it>p53</it>. Loss of p53 results in increased expression of CD44...
Main Authors: | Yoshida Go J, Fuchimoto Yasushi, Osumi Tomoo, Shimada Hiroyuki, Hosaka Seiichi, Morioka Hideo, Mukai Makio, Masugi Yohei, Sakamoto Michiie, Kuroda Tatsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/444 |
Similar Items
-
Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature
by: Kast Karin, et al.
Published: (2012-06-01) -
Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study
by: Peter G. Hendrickson, et al.
Published: (2020-11-01) -
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol
by: Miriam Dixon-Zegeye, et al.
Published: (2024-02-01) -
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
by: Francesco Paduano, et al.
Published: (2021-09-01) -
Li–Fraumeni Syndrome: Mutation of <i>TP53</i> Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
by: Valentina Rocca, et al.
Published: (2022-07-01)